Cumberland Angela L, Palliser Hannah K, Crombie Gabrielle K, Walker David W, Hirst Jonathan J
University of Newcastle, School of Biomedical Sciences and Pharmacy, Newcastle 2308, New South Wales, Australia; Hunter Medical Research Institute, Mothers and Babies Research Centre, Newcastle 2305, New South Wales, Australia.
University of Newcastle, School of Biomedical Sciences and Pharmacy, Newcastle 2308, New South Wales, Australia; Hunter Medical Research Institute, Mothers and Babies Research Centre, Newcastle 2305, New South Wales, Australia.
Int J Dev Neurosci. 2017 May;58:50-58. doi: 10.1016/j.ijdevneu.2017.02.001. Epub 2017 Feb 9.
Neurosteroids are essential for aiding proper fetal neurodevelopment. Pregnancy compromises such as preterm birth, prenatal stress and intrauterine growth restriction are associated with an increased risk of developing behavioural and mood disorders, particularly during adolescence. These pathologies involve the premature loss or alteration of trophic steroid hormones reaching the fetus leading to impaired neurodevelopment. While the specific programming mechanisms are yet to be fully elucidated, in adult life, dysfunctions of allopregnanolone action are prevalent in individuals with depression, post-traumatic stress disorder and anxiety disorders. The objective of this study was to assess if changes in concentrations of the neurosteroid, allopregnanolone, may be a fetal programming factor in priming the brain towards a negative behavioural phenotype during the childhood to adolescent period using a guinea pig model. Pregnant guinea pigs received either vehicle (45% (2-hydroxypropyl)-β-cyclodextrin) or the 5α-reductase inhibitor, finasteride (25mg/kg maternal weight) from gestational age 60 until spontaneous delivery (∼71days gestation). Male and female offspring from vehicle and finasteride treated dams were tested at postnatal day 20 (juvenile-equivalence) in an open field arena, and hippocampus and amygdala subsequently assessed for neurological changes in markers of development and GABA production pathways 24h later. Females with reduced allopregnanolone exposure in utero displayed increased neophobic-like responses to a change in their environment compared to female controls. There were no differences in the neurodevelopmental markers assessed; MAP2, NeuN, MBP, GFAP or GAD67 between intrauterine finasteride or vehicle exposure, in either the hippocampus or amygdala whereas GAT1 staining was decreased. This study indicates that an intrauterine reduction in the supply of allopregnanolone programs vulnerability of female offspring to anxiety-like disorders in juvenility without impacting long term allopregnanolone concentrations.
神经甾体对于促进胎儿正常的神经发育至关重要。诸如早产、产前应激和宫内生长受限等妊娠并发症与行为和情绪障碍的发生风险增加有关,尤其是在青春期。这些病症涉及到达胎儿的营养甾体激素过早丧失或改变,导致神经发育受损。虽然具体的编程机制尚未完全阐明,但在成年期,别孕烯醇酮作用功能障碍在患有抑郁症、创伤后应激障碍和焦虑症的个体中很普遍。本研究的目的是使用豚鼠模型评估神经甾体别孕烯醇酮浓度的变化是否可能是一种胎儿编程因素,在儿童期到青春期使大脑倾向于出现负面行为表型。怀孕的豚鼠从妊娠60天直到自然分娩(约妊娠71天)接受载体(45%(2-羟丙基)-β-环糊精)或5α-还原酶抑制剂非那雄胺(25mg/kg母体体重)。来自接受载体和非那雄胺处理的母鼠的雄性和雌性后代在出生后第20天(相当于幼年)在旷场实验中进行测试,随后在24小时后评估海马体和杏仁核中发育标志物和GABA产生途径的神经学变化。与雌性对照组相比,子宫内别孕烯醇酮暴露减少的雌性对环境变化表现出增加的类似新事物恐惧的反应。在评估的神经发育标志物中没有差异;海马体或杏仁核中宫内非那雄胺或载体暴露之间的微管相关蛋白2(MAP2)、神经元核抗原(NeuN)、髓鞘碱性蛋白(MBP)、胶质纤维酸性蛋白(GFAP)或谷氨酸脱羧酶67(GAD67)没有差异,而γ-氨基丁酸转运体1(GAT1)染色减少。这项研究表明,子宫内别孕烯醇酮供应减少会使雌性后代在幼年时易患类似焦虑症,而不会影响长期的别孕烯醇酮浓度。